Why is my liver fatty on ultrasound?

A fatty liver on ultrasound means excess fat has accumulated in your liver cells, often due to metabolic factors like obesity, insulin resistance, or excessive alcohol consumption. This condition, called hepatic steatosis, is reversible through lifestyle changes including weight loss, dietary improvements, and regular exercise.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Fatty Liver on Ultrasound

If your recent ultrasound revealed a fatty liver, you're not alone. This finding, medically known as hepatic steatosis, affects approximately 25-30% of adults worldwide. A fatty liver means that fat makes up more than 5-10% of your liver's weight, which appears as increased brightness or 'hyperechogenicity' on ultrasound imaging.

The good news is that fatty liver disease is often reversible, especially when caught early. Understanding why this happens and what you can do about it is crucial for protecting your long-term health. While a fatty liver often produces no symptoms initially, it can progress to more serious conditions like liver inflammation (steatohepatitis), fibrosis, and even cirrhosis if left unaddressed.

What Causes Fat Accumulation in Your Liver?

Your liver plays a central role in metabolizing fats, proteins, and carbohydrates. When this delicate balance is disrupted, fat begins to accumulate in liver cells. There are two main categories of fatty liver disease: alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD), with NAFLD being far more common.

Risk Factors for Fatty Liver Disease

Risk factors are often interconnected, and addressing multiple factors simultaneously yields the best results.
Risk FactorImpact LevelPrevalence in NAFLDReversibility
ObesityObesity (BMI >30)High70-80%Highly reversible with weight loss
Type 2 DiabetesType 2 DiabetesHigh50-70%Manageable with glucose control
High TriglyceridesHigh TriglyceridesModerate-High60-70%Reversible with diet/medication
Metabolic SyndromeMetabolic SyndromeHigh80-90%Reversible with lifestyle changes
Sedentary LifestyleSedentary LifestyleModerate40-50%Completely reversible

Risk factors are often interconnected, and addressing multiple factors simultaneously yields the best results.

Metabolic Factors

The most significant contributors to NAFLD are metabolic in nature. Insulin resistance, which occurs when your cells don't respond properly to insulin, causes your liver to produce and store more fat. This is why fatty liver disease is strongly associated with metabolic syndrome, a cluster of conditions including high blood pressure, elevated blood sugar, excess abdominal fat, and abnormal cholesterol levels. Understanding your metabolic health through comprehensive biomarker testing can reveal these underlying risk factors before they progress.

Lifestyle and Dietary Factors

Diet plays a crucial role in liver fat accumulation. Consuming excessive calories, particularly from refined carbohydrates and fructose (found in sugary drinks and processed foods), directly contributes to liver fat storage. A sedentary lifestyle compounds this problem by reducing your body's ability to burn fat efficiently. Even modest weight gain of 5-10 pounds can increase liver fat content significantly.

Other Contributing Factors

  • Genetics: Certain genetic variations affect how your body processes and stores fat
  • Medications: Some drugs including corticosteroids, tamoxifen, and certain antipsychotics can cause fat accumulation
  • Rapid weight loss: Paradoxically, losing weight too quickly can temporarily worsen fatty liver
  • Gut microbiome imbalances: Emerging research shows that gut bacteria influence liver fat metabolism
  • Sleep apnea: Poor sleep quality and oxygen deprivation during sleep are linked to fatty liver disease

Understanding these various causes helps explain why fatty liver disease has become so prevalent and why a comprehensive approach to treatment is necessary.

Recognizing Symptoms and Warning Signs

Most people with fatty liver disease experience no symptoms in the early stages, which is why it's often discovered incidentally during imaging for other reasons. However, as the condition progresses, you might notice subtle signs that warrant attention.

Early Stage Symptoms

When symptoms do occur in early-stage fatty liver disease, they tend to be non-specific and easily attributed to other causes. These may include persistent fatigue that doesn't improve with rest, mild discomfort or fullness in the upper right abdomen, and unexplained weight loss or loss of appetite. Some people also report difficulty concentrating or 'brain fog,' which may be related to the liver's reduced ability to filter toxins effectively.

Advanced Warning Signs

As fatty liver progresses to inflammation (NASH) or fibrosis, more concerning symptoms may develop. These include yellowing of the skin or eyes (jaundice), swelling in the legs and abdomen, spider-like blood vessels on the skin, and easy bruising or bleeding. If you experience any of these symptoms, immediate medical evaluation is essential.

Essential Blood Tests for Fatty Liver Assessment

While ultrasound can detect fatty liver, blood tests provide crucial information about liver function, the degree of inflammation, and associated metabolic factors. Regular monitoring of these biomarkers helps track your progress and guide treatment decisions.

Liver Function Tests

  • ALT (Alanine Aminotransferase): The most specific marker for liver cell damage, elevated in fatty liver disease
  • AST (Aspartate Aminotransferase): Often elevated alongside ALT, the AST/ALT ratio helps determine the cause
  • ALP (Alkaline Phosphatase): Can indicate bile duct problems or liver damage
  • Bilirubin: Elevated levels suggest impaired liver function
  • Albumin and Total Protein: Reflect the liver's synthetic function

For comprehensive liver health monitoring, regular testing of these markers along with metabolic indicators provides the most complete picture. The Heart & Metabolic Program includes all essential liver enzymes plus metabolic markers that reveal underlying causes of fatty liver.

Metabolic and Inflammatory Markers

Beyond liver enzymes, several other biomarkers are critical for understanding fatty liver disease. Fasting glucose and HbA1c reveal insulin resistance and diabetes risk, while lipid panels (including triglycerides, HDL, and LDL cholesterol) often show the characteristic pattern of high triglycerides and low HDL seen in fatty liver. High-sensitivity CRP indicates systemic inflammation, and ferritin levels can be elevated in NASH, suggesting iron overload and oxidative stress.

Upload your blood test results to track your progress

Seamlessly upload 3rd party biomarker & blood tests to track your whole health in 1 dashboard. Understand what each blood test means and how it fits into the bigger picture of your body and health.

Get diet and lifestyle recommendations based on your blood results, health profile and health goals. You'll also receive a custom supplement recommendation for the precise nutrients your body craves.

Upload Past Blood Test Results

Click or drag file to upload

Once you upload your report, we'll extract the results for your review. Works with top labs including Quest Diagnostics, LabCorp, BioReference, EverlyWell, LetsGetChecked and hundreds of other labs.

Evidence-Based Strategies to Reverse Fatty Liver

The encouraging news about fatty liver disease is that it's one of the most responsive conditions to lifestyle interventions. Research consistently shows that even modest improvements in diet and activity can significantly reduce liver fat content.

Dietary Interventions

The Mediterranean diet has the strongest evidence for reversing fatty liver disease. This eating pattern emphasizes whole grains, fruits, vegetables, lean proteins, and healthy fats from olive oil and nuts. Studies show that following a Mediterranean diet can reduce liver fat by 30-40% within 6-12 weeks, even without significant weight loss.

  • Limit fructose intake: Avoid sugary drinks and processed foods high in added sugars
  • Choose complex carbohydrates: Replace refined grains with whole grains to improve insulin sensitivity
  • Increase omega-3 fatty acids: Include fatty fish, walnuts, and flaxseeds to reduce liver inflammation
  • Add coffee: 2-3 cups of coffee daily has been shown to protect against liver fibrosis
  • Consider intermittent fasting: Time-restricted eating can improve insulin sensitivity and reduce liver fat

Exercise and Weight Management

Physical activity directly reduces liver fat independent of weight loss. Both aerobic exercise and resistance training are beneficial, with studies showing that 150 minutes of moderate-intensity exercise weekly can reduce liver fat by 20-30%. High-intensity interval training (HIIT) appears particularly effective, potentially due to its impact on insulin sensitivity and fat oxidation.

Weight loss remains the most effective intervention for fatty liver disease. Losing just 5% of body weight can reduce liver fat significantly, while 7-10% weight loss can reduce inflammation and even reverse early fibrosis. However, aim for gradual weight loss of 1-2 pounds per week, as rapid weight loss can temporarily worsen liver inflammation.

When to Seek Medical Intervention

While lifestyle changes are the cornerstone of fatty liver treatment, certain situations require medical evaluation and potentially pharmaceutical intervention. If your liver enzymes remain elevated despite lifestyle changes, or if you have signs of advanced liver disease, working with a hepatologist or gastroenterologist becomes essential.

Currently, no medications are specifically approved for treating NAFLD, but several are being studied in clinical trials. Vitamin E has shown benefits in non-diabetic adults with NASH, while pioglitazone may help those with diabetes. Some patients benefit from medications that address underlying conditions like diabetes (metformin, GLP-1 agonists) or high cholesterol (statins), which can indirectly improve liver health.

For those interested in understanding their complete metabolic and liver health picture, comprehensive testing that includes liver enzymes, metabolic markers, and inflammatory indicators provides the most actionable insights. Upload your existing lab results to SiPhox Health's free analysis service to get personalized recommendations based on your current biomarkers and track your progress over time.

Taking Control of Your Liver Health

A fatty liver diagnosis can feel overwhelming, but it's important to remember that this condition is highly treatable. The key is taking action early, before progression to more serious liver disease. Start with small, sustainable changes: replace sugary drinks with water or unsweetened tea, add a 20-minute walk to your daily routine, and focus on whole, unprocessed foods.

Regular monitoring through blood tests helps you track your progress and stay motivated. Many people see improvements in liver enzymes within 4-6 weeks of lifestyle changes, with more significant reductions in liver fat occurring over 3-6 months. Remember that reversing fatty liver is a marathon, not a sprint. Consistency in your healthy habits matters more than perfection.

By understanding why your liver became fatty and implementing evidence-based strategies to address the root causes, you can not only reverse fatty liver disease but also improve your overall metabolic health, reducing your risk of diabetes, heart disease, and other chronic conditions. Your liver has a remarkable ability to heal itself when given the right conditions. With commitment to lifestyle changes and regular monitoring, you can restore your liver health and protect this vital organ for years to come.

References

  1. Younossi, Z. M., Koenig, A. B., Abdelatif, D., Fazel, Y., Henry, L., & Wymer, M. (2016). Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology, 64(1), 73-84.[Link][PubMed][DOI]
  2. Romero-Gómez, M., Zelber-Sagi, S., & Trenell, M. (2017). Treatment of NAFLD with diet, physical activity and exercise. Journal of Hepatology, 67(4), 829-846.[Link][PubMed][DOI]
  3. Vilar-Gomez, E., Martinez-Perez, Y., Calzadilla-Bertot, L., Torres-Gonzalez, A., Gra-Oramas, B., Gonzalez-Fabian, L., ... & Romero-Gomez, M. (2015). Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology, 149(2), 367-378.[Link][PubMed][DOI]
  4. Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., ... & Sanyal, A. J. (2018). The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. Hepatology, 67(1), 328-357.[Link][PubMed][DOI]
  5. Zelber-Sagi, S., Salomone, F., & Mlynarsky, L. (2016). The Mediterranean dietary pattern as the diet of choice for non-alcoholic fatty liver disease: Evidence and plausible mechanisms. Liver International, 36(7), 936-949.[Link][PubMed][DOI]
  6. Keating, S. E., Hackett, D. A., George, J., & Johnson, N. A. (2012). Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. Journal of Hepatology, 57(1), 157-166.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my liver enzymes at home?

You can test your liver enzymes at home with SiPhox Health's Heart & Metabolic Program, which includes comprehensive liver function testing with ALT, AST, ALP, bilirubin, and other essential markers. The program provides lab-quality results and personalized insights to help you monitor and improve your liver health.

How long does it take to reverse fatty liver?

With consistent lifestyle changes, you can see improvements in liver enzymes within 4-6 weeks. Significant reduction in liver fat typically occurs over 3-6 months. Studies show that losing 5-10% of body weight combined with regular exercise can reverse fatty liver in most cases within 6-12 months.

Can fatty liver disease be completely cured?

Yes, simple fatty liver (steatosis) is completely reversible through lifestyle modifications. Even early-stage inflammation (NASH) can be reversed. However, once significant scarring (fibrosis) develops, the damage may be permanent, though progression can still be halted with proper management.

What foods should I avoid with fatty liver?

Avoid sugary drinks, processed foods high in fructose, refined carbohydrates, fried foods, and excessive alcohol. Limit red meat and full-fat dairy products. Focus instead on whole grains, lean proteins, vegetables, fruits, and healthy fats from sources like olive oil and nuts.

Is fatty liver disease genetic?

While lifestyle factors are the primary cause, genetics play a role in about 20-30% of cases. Certain genetic variants affect how your body processes fats and can increase susceptibility. However, even with genetic predisposition, lifestyle modifications remain highly effective for managing the condition.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Clinical Product Operations

Director of Clinical Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, contributing to patents, launching health-related products, and turning diagnostics into actionable tools.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Robert Lufkin, MD

Robert Lufkin, MD

Advisor

Physician/medical school professor (UCLA and USC) and New York Times bestselling author empowering people to take back their metabolic health with lifestyle and other tools. A veteran of the Today Show, USA Today, and a regular contributor to FOX and other network news stations, his weekly video podcast reaches over 500,000 people. After reversing chronic disease and transforming his own life he is making it his mission to help others do the same.

His latest book, ‘Lies I Taught In Medical School’ is an instant New York Times bestseller and has re-framed how we think about metabolic health and longevity. In addition to being a practicing physician, he is author of over 200 peer reviewed scientific papers and 14 books that are available in fourteen languages.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details